- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Anixa Biosciences Inc (ANIX)
Track today's live Anixa Biosciences (ANIX) share price, performance and key data on this page with our current NASDAQ:ANIX stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Anixa Biosciences share price on the NASDAQ exchange. Use the dropdown to switch exchange for the ANIX share price, head to our technical summary section, which provides analysis on Anixa Biosciences share price buy/sell indicators using real-time data (or discuss the Anixa Biosciences (ANIX) stock price today with other investors in the Anixa Biosciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ANIX share price (ISIN: US03528H1095) to enhance your trading decisions with our free investment tools and resources.
What Is the Anixa Biosciences Inc Share Price Today?
The Anixa Biosciences share price today is 2.720.
What Is the Stock Symbol for Anixa Biosciences Inc
The stock symbol (or 'ticker') for Anixa Biosciences Inc is "ANIX."
What Stock Exchange Does Anixa Biosciences Inc Trade On?
Anixa Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Anixa Biosciences Inc a Good Stock to Buy?
Determining whether Anixa Biosciences (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ANIX share price (ISIN: US03528H1095) to enhance your trading decisions with our free investment tools and resources.
What Is the Anixa Biosciences Inc Share Price Today?
The Anixa Biosciences share price today is 2.720.
What Is the Stock Symbol for Anixa Biosciences Inc
The stock symbol (or 'ticker') for Anixa Biosciences Inc is "ANIX."
What Stock Exchange Does Anixa Biosciences Inc Trade On?
Anixa Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Anixa Biosciences Inc a Good Stock to Buy?
Determining whether Anixa Biosciences (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
2.720
+0.065(+2.45%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.630
2.750
52 wk Range
2.320
5.457
ANIX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.6302.750
52 wk Range
2.3205.457
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ANIX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
9.750
Upside
+258.46%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.750
(+258.46% Upside)
Earnings
Latest Release
11/09/2026
EPS / Forecast
-0.08 / -0.08
Revenue / Forecast
-- / --
Compare ANIX to Peers and Sector
Metrics to compare | ANIX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANIXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.8x | −1.9x | −0.3x | |
PEG Ratio | −0.89 | 0.01 | 0.00 | |
Price/Book | 6.3x | 3.2x | 2.6x | |
Price / LTM Sales | - | 4.5x | 2.9x | |
Upside (Analyst Target) | 267.2% | 361.9% | 64.3% | |
Fair Value Upside | Unlock | 16.5% | 10.0% | Unlock |
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Anixa Biosciences (NASDAQ: ANIX) Share Price Today?
The Anixa Biosciences stock price today is 2.720 USD.
What Stock Exchange Does Anixa Biosciences (ANIX) Trade On?
Anixa Biosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Anixa Biosciences?
The stock symbol (also called a 'ticker') for Anixa Biosciences is "ANIX."
What Is the Current Anixa Biosciences Market Capitalisation?
As of today, Anixa Biosciences (NASDAQ: ANIX) market cap is 94.560M USD.
What Is Anixa Biosciences's (ANIX) Earnings Per Share (TTM)?
The Anixa Biosciences EPS is currently -0.31 (Trailing Twelve Months).
When Is the Next Anixa Biosciences Earnings Date?
Anixa Biosciences's next earnings report will be released on 06/01/2027.
Is ANIX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Anixa Biosciences moving averages and other technical indicators, the daily buy/sell signal for ANIX stock is Strong Sell.
How Many Times Has Anixa Biosciences Stock Split?
Anixa Biosciences has split 5 times. (See the ANIX stock split history page for full effective split date and price information.)
How Many Employees Does Anixa Biosciences Have?
Anixa Biosciences has 4 employees, based on their latest Companies House report.
What is the current trading status of Anixa Biosciences (NASDAQ: ANIX)?
As of 15/10/2026, Anixa Biosciences (ANIX) is trading at a share price of 2.720 USD, with a previous close of 2.655 USD. The stock has fluctuated within a day range of 2.630 USD to 2.750 USD, while its 52-week range spans from 2.320 USD to 5.457 USD.
What Is Anixa Biosciences (ANIX) Price Target According to Analysts?
The average 12-month price target for Anixa Biosciences is 9.750 USD, with a high estimate of 14 USD and a low estimate of 6 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +258.46% Upside potential.
What Is the ANIX Premarket Price?
ANIX's last pre-market stock price is 2.720 USD. The pre-market share volume is 2,070.000, and the stock has decreased by 0.065, or 2.450%.
What Is the ANIX After Hours Price?
ANIX's last after hours stock price is 2.450 USD, the stock has decreased by -0.205, or -7.720%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.